The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug ...

Eptinezumab plus education reduces monthly migraine days in adults with chronic migraine and medication-overuse headache.

Merck & Co., Inc. (NYSE:MRK) is one of the 8 Best Counter Cyclical Stocks to Buy Right Now. On April 21, 2026, Merck & Co., ...

Merck stock slides as Keytruda-based triplet therapy misses main goals in a late-stage study in first-line advanced renal ...

Cancer Calculus Latest breaking news, pictures, photos and Video News. Find Cancer Calculus news headlines, photos, videos, comments, blog posts and opinion at The Indian Express.

On the Wednesday, April 15, 2026, episode of The Excerpt podcast: Prices for cutting-edge medical treatments can balloon in the U.S. health care system, leading to higher costs for the employer, ...

A cross-border investigation by DW and ICIJ reveals how pricing and patents helped turn a life-saving medicine into one of the world's best selling drugs while leaving many patients struggling to ...

First approved by the US FDA in 2014 for advanced skin cancer, Keytruda is now used globally for certain lung cancers, cervical cancer, renal cell cancer and aggressive breast cancer, among others.

At least P102.5 million worth of counterfeit medicine was seized in an entrapment operation that led to the arrest of four ...

FDA approves a PD-L1 test to help identify patients with esophageal or gastroesophageal junction (GEJ) cancer who may benefit from Keytruda. Agilent Technologies Inc. announced that the U.S. Food and ...

Merck will acquire Terns for $53 per share in cash, amounting to an equity value of about $6.7 billion. This is the third multibillion-dollar acquisition for Merck over the past year as it looks to ...